LUNG vs BVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

LUNG

50.7
AI Score
VS
BVS Wins

BVS

56.1
AI Score

Investment Advisor Scores

LUNG

51score
Recommendation
HOLD

BVS

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LUNG BVS Winner
Revenue 20.59M 132.09M BVS
Net Income -13.65M 3.11M BVS
Gross Margin 77.9% 68.7% LUNG
Net Margin -66.3% 2.4% BVS
Operating Income -12.96M 8.42M BVS
ROE -29.8% 1.6% BVS
ROA -11.4% 0.5% BVS
Total Assets 119.97M 650.54M BVS
Cash 61.57M 35.85M LUNG
Debt/Equity 0.82 1.34 LUNG
Current Ratio 4.91 1.69 LUNG
Free Cash Flow -10.11M 8.36M BVS

Relative Price Performance (Last 90 Days)

LUNG 1M: +52.5% · 3M: +57.0% BVS 1M: +28.5% · 3M: +33.2%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.6% over 20 days), RSI 78

RSI (14): 77.5 · Price: $2.12

BVS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 70

RSI (14): 70.5 · Price: $13.47

Fundamentals Snapshot

Metric LUNG BVS
Market Cap
Forward P/E -2.3 14.8
Trailing P/E 32.1
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.8% 0.7%
Operating Margin -0.4% 0.1%
EPS -1.15 0.41
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BVS is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.